These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 29063135)

  • 1. Metal chelators and neurotoxicity: lead, mercury, and arsenic.
    Bjørklund G; Mutter J; Aaseth J
    Arch Toxicol; 2017 Dec; 91(12):3787-3797. PubMed ID: 29063135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization of heavy metals by newer, therapeutically useful chelating agents.
    Aposhian HV; Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Dart RC; Aposhian MM
    Toxicology; 1995 Mar; 97(1-3):23-38. PubMed ID: 7716789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chelation in metal intoxication--Principles and paradigms.
    Aaseth J; Skaug MA; Cao Y; Andersen O
    J Trace Elem Med Biol; 2015; 31():260-6. PubMed ID: 25457281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chelation therapy in intoxications with mercury, lead and copper.
    Cao Y; Skaug MA; Andersen O; Aaseth J
    J Trace Elem Med Biol; 2015; 31():188-92. PubMed ID: 24894443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are we ready to replace dimercaprol (BAL) as an arsenic antidote?
    Mückter H; Liebl B; Reichl FX; Hunder G; Walther U; Fichtl B
    Hum Exp Toxicol; 1997 Aug; 16(8):460-5. PubMed ID: 9292286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review on Coordination Properties of Thiol-Containing Chelating Agents Towards Mercury, Cadmium, and Lead.
    Bjørklund G; Crisponi G; Nurchi VM; Cappai R; Buha Djordjevic A; Aaseth J
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31489907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of chelation in the treatment of arsenic and mercury poisoning.
    Kosnett MJ
    J Med Toxicol; 2013 Dec; 9(4):347-54. PubMed ID: 24178900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroanalytical and isothermal calorimetric study of As(III) complexation by the metal poisoning remediators, 2,3-dimercapto-1-propanesulfonate and meso-2,3-dimercaptosuccinic acid.
    Cavanillas S; Chekmeneva E; Ariño C; Díaz-Cruz JM; Esteban M
    Anal Chim Acta; 2012 Oct; 746():47-52. PubMed ID: 22975179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DMSA, DMPS, and DMPA--as arsenic antidotes.
    Aposhian HV; Carter DE; Hoover TD; Hsu CA; Maiorino RM; Stine E
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S58-70. PubMed ID: 6327446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic Toxicity: Molecular Targets and Therapeutic Agents.
    Nurchi VM; Djordjevic AB; Crisponi G; Alexander J; Bjørklund G; Aaseth J
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32033229
    [No Abstract]   [Full Text] [Related]  

  • 12. Arsenic induced blood and brain oxidative stress and its response to some thiol chelators in rats.
    Flora SJ; Bhadauria S; Pant SC; Dhaked RK
    Life Sci; 2005 Sep; 77(18):2324-37. PubMed ID: 15964026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of meso 2,3-dimercaptosuccinic acid or 2,3-dimercaptopropane 1-sulfonate in chronic arsenic intoxication in rats.
    Flora SJ; Dube SN; Arora U; Kannan GM; Shukla MK; Malhotra PR
    Biometals; 1995 Apr; 8(2):111-6. PubMed ID: 7734923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of combined chelation in lead intoxication.
    Tandon SK; Singh S; Jain VK
    Chem Res Toxicol; 1994; 7(5):585-9. PubMed ID: 7841335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic and lead induced free radical generation and their reversibility following chelation.
    Flora SJ; Flora G; Saxena G; Mishra M
    Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):26-47. PubMed ID: 17519110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chelators as antidotes of metal toxicity: therapeutic and experimental aspects.
    Blanusa M; Varnai VM; Piasek M; Kostial K
    Curr Med Chem; 2005; 12(23):2771-94. PubMed ID: 16305472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of arsenic-induced oxidative stress, DNA damage, and metal imbalance to combined administration of DMSA and monoisoamyl-DMSA during chronic arsenic poisoning in rats.
    Bhadauria S; Flora SJ
    Cell Biol Toxicol; 2007 Mar; 23(2):91-104. PubMed ID: 17086449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity.
    Miller AL
    Altern Med Rev; 1998 Jun; 3(3):199-207. PubMed ID: 9630737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of dimercapto chelating agents for the treatment of poisoning by percutaneously applied dichloro(2-chlorovinyl)arsine in rabbits.
    Inns RH; Rice P
    Hum Exp Toxicol; 1993 May; 12(3):241-6. PubMed ID: 8100435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention by chelating agents of metal-induced developmental toxicity.
    Domingo JL
    Reprod Toxicol; 1995; 9(2):105-13. PubMed ID: 7795320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.